Imamura, T.; Narang, N.; Onoda, H.; Tanaka, S.; Ushijima, R.; Sobajima, M.; Fukuda, N.; Ueno, H.; Kinugawa, K.
Negative Prognostic Impact of Mineralocorticoid Receptor Antagonist in Elderly Patients Receiving TAVR. J. Clin. Med. 2023, 12, 3742.
https://doi.org/10.3390/jcm12113742
AMA Style
Imamura T, Narang N, Onoda H, Tanaka S, Ushijima R, Sobajima M, Fukuda N, Ueno H, Kinugawa K.
Negative Prognostic Impact of Mineralocorticoid Receptor Antagonist in Elderly Patients Receiving TAVR. Journal of Clinical Medicine. 2023; 12(11):3742.
https://doi.org/10.3390/jcm12113742
Chicago/Turabian Style
Imamura, Teruhiko, Nikhil Narang, Hiroshi Onoda, Shuhei Tanaka, Ryuichi Ushijima, Mitsuo Sobajima, Nobuyuki Fukuda, Hiroshi Ueno, and Koichiro Kinugawa.
2023. "Negative Prognostic Impact of Mineralocorticoid Receptor Antagonist in Elderly Patients Receiving TAVR" Journal of Clinical Medicine 12, no. 11: 3742.
https://doi.org/10.3390/jcm12113742
APA Style
Imamura, T., Narang, N., Onoda, H., Tanaka, S., Ushijima, R., Sobajima, M., Fukuda, N., Ueno, H., & Kinugawa, K.
(2023). Negative Prognostic Impact of Mineralocorticoid Receptor Antagonist in Elderly Patients Receiving TAVR. Journal of Clinical Medicine, 12(11), 3742.
https://doi.org/10.3390/jcm12113742
